Jove
Visualize
Contact Us

Related Experiment Videos

Prostate-specific genes: present status and future direction.

R K Naz1, E A Herness

  • 1Division of Research, HEB Room 211, Medical College of Ohio, 3055 Arlington Avenue, Toledo, OH 43614-5806, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|September 5, 2001
PubMed
Summary

New prostate-specific molecules are needed to improve early detection of prostate cancer and benign prostatic hyperplasia (BPH). Current prostate-specific antigen (PSA) testing lacks sufficient sensitivity and specificity for effective clinical management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Curcumin as a potential non-steroidal contraceptive with spermicidal and microbicidal properties.

European journal of obstetrics, gynecology, and reproductive biology·2014
Same author

Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis).

Andrologia·2014
Same author

Do men with prostate abnormalities (prostatitis/benign prostatic hyperplasia/prostate cancer) develop immunity to spermatozoa or seminal plasma?

International journal of andrology·2012
Same author

Isolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development.

Human reproduction (Oxford, England)·2008
Same author

Human synthetic peptide vaccine for contraception targeting sperm.

Archives of andrology·2004
Same author

Monoclonal antibody against human sperm-specific YLP12 peptide sequence involved in oocyte binding.

Archives of andrology·2002
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Urology
  • Oncology
  • Biochemistry

Background:

  • Prostate cancer is a leading cause of cancer mortality in men.
  • Benign prostatic hyperplasia (BPH) affects a large percentage of aging men.
  • Current diagnostic reliance on prostate-specific antigen (PSA) has limitations in sensitivity and specificity.

Purpose of the Study:

  • To review prostate-specific genes identified in scientific literature.
  • To assess their claimed roles in normal and abnormal prostate growth.
  • To identify gaps in the search for an ideal prostate cancer and BPH biomarker.

Main Methods:

  • Literature review of published studies on prostate-specific genes.
  • Analysis of reported functions in prostate development and disease.

Related Experiment Videos

  • Synthesis of current research status and future directions.

    • Main Results:

    • Several candidate prostate-specific molecules have been reported.
    • These molecules are investigated for their roles in prostate growth and development.
    • Existing biomarkers like PSA show limitations in early detection.

    Conclusions:

    • There is an ongoing need for more sensitive and specific biomarkers for prostate cancer and BPH.
    • Further research is required to identify and validate novel prostate-specific antigens.
    • Addressing literature gaps is crucial for advancing early clinical management.